Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Glenn L. Cooper Md currently holds 35,975 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn L. Cooper Md has been a net seller of RGEN stock. They have purchased $212.6K and sold $669.4K worth of shares.
Glenn L. Cooper Md's most recent insider trade was on May 23, 2019, when they sold 4,734 shares at $66.91 per share.
Glenn L. Cooper Md serves as Executive at REPLIGEN CORP (RGEN). They have executed 27 insider transactions totaling $882.0K over their tenure at the company.
Glenn L. Cooper Md holds the position of Executive at REPLIGEN CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Glenn L. Cooper Md has shown a selling trading pattern, with $212.6K in total purchases and $669.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Glenn L. Cooper Md was on May 23, 2019, when they sold $316.8K worth of RGEN shares. This transaction involved 4,734 shares at $66.91 per share.
Glenn L. Cooper Md currently owns 35,975 shares of REPLIGEN CORP (RGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Glenn L. Cooper Md's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Glenn L. Cooper Md has 27 Form 4 filings on record as an insider at REPLIGEN CORP.
Set alerts for Glenn L. Cooper Md and 40,000+ other insiders.